UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934
Date of Report: August 28, 2023
Commission File Number: 001-39307
Legend Biotech
Corporation
(Exact Name of Registrant as Specified in its Charter)
2101 Cottontail Lane
Somerset, New Jersey 08873
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Legend Biotech Corporation (the “Company”) will hold its Annual General Meeting of Shareholders (the “Meeting”) on September 21, 2023 beginning at 9:30 a.m. (local time) at the Company’s offices at 2201 Cottontail Lane,
Somerset, NJ 08873, USA.
Materials made available in connection with the Meeting are available on the Company's website at www.legendbiotech.com. The information contained in, or that can be accessed
through, the Company’s website is not a part of this filing.
The following documents regarding the Meeting, each of which are attached as an exhibit hereto, are incorporated by reference herein. This report on Form 6-K, including the exhibits attached hereto, shall be
deemed to be incorporated by reference in the registration statements of the Company on Form F-3 (Nos. 333-257609, 333-257625, and 333-272222) and Form S-8 (No. 333-239478), to the extent not superseded by documents or reports subsequently filed.
EXHIBIT INDEX
| |
|
|
|
Exhibit
|
|
Title
|
| |
|
|
99.1
|
|
Proxy Statement
|
|
99.2
|
|
Notice of Annual General Meeting
|
|
99.3
|
|
Form of Proxy
|
|
99.4
|
|
Voting Card and Instructions for ADS Holders
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| |
LEGEND BIOTECH CORPORATION
(Registrant)
|
| |
|
|
|
August 28, 2023
|
By:
|
|
| |
|
Ying Huang, Ph.D.
|
| |
|
Chief Executive Officer
|